[Cancers of the breast at metastatic high-risk: prediction of survival by steroidal receptors]

Bull Cancer. 1989;76(1):33-41.
[Article in French]

Abstract

From 1982 to 1985, 279 patients with locally advanced breast cancer have been treated with induction chemotherapy, adjusted loco-regional treatment (surgery and/or radiotherapy) and adjuvant chemotherapy with or without immunostimulation. Overall and relapse free survivals are better for tumors with estrogen and progesterone receptors (EPR). For these patients, we may hope that tumoral reduction with hormonotherapy would get the same overall and relapse-free survivals as induction chemotherapy.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Breast Neoplasms / analysis
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality*
  • Breast Neoplasms / physiopathology
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Prognosis
  • Receptors, Estrogen / analysis*
  • Receptors, Progesterone / analysis*
  • Risk Factors

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone